Prescription Drug Pricing
Health+Benefits
What Prescription Drug Importation Could Mean for Brokers
Q&A with David Shore, SVP, Enterprise Strategy & Risk Management at Borislow Ins...
August 14, 2019
Health+Benefits
It’s Personal
Can insurers and PBMs harness their combined data to truly know the patient bett...
May 24, 2019
Health+Benefits
Prescription Back-Door Discounts
Q&A with Steve Wojcik, VP, National Business Group on Health; Caleb Alexander, c...
April 19, 2019
Industry
Cloudy…with a Chance of Optimism
Blue Dogs to bipartisanship to herbal tea—The Council’s government affairs t...
January 22, 2019
Health+Benefits
Tech Giants Poised to Shift Healthcare Landscape
Tech companies are banging down the doors of the healthcare industry, infiltrati...
December 5, 2018
Health+Benefits
Pharmacy Supply Chain: What You Need to Know
Despite the Trump administration’s push to lower drug prices, costs have not y...
November 8, 2018
Health+Benefits
Medicare Part B Drug Pricing to Mirror Foreign Prices?
CMS released an advanced notice of proposed rulemaking—with the spring of 2019...
November 8, 2018
Health+Benefits
What Does the Removal of Pharmacy ‘Gag Clauses’ Mean for Consumers?
The Senate passed The Patient Right to Know Drug Prices Act, which bans gag clau...
September 20, 2018
Health+Benefits
Cigna-Express Scripts Deal Gets the Green Light
Cigna’s acquisition of Express Scripts was approved by federal officials
September 20, 2018
Industry
Meeting Between the Aisle
Q&A with Reps. Tom Reed and Josh Gottheimer, co-chairs of the Problem Solvers Ca...
August 30, 2018